Canada markets closed
  • S&P/TSX

    19,171.66
    -32.04 (-0.17%)
     
  • S&P 500

    4,124.66
    -16.93 (-0.41%)
     
  • DOW

    33,730.89
    +53.62 (+0.16%)
     
  • CAD/USD

    0.7991
    +0.0002 (+0.03%)
     
  • CRUDE OIL

    62.76
    -0.39 (-0.62%)
     
  • BTC-CAD

    78,937.23
    -729.35 (-0.92%)
     
  • CMC Crypto 200

    1,368.33
    -7.45 (-0.54%)
     
  • GOLD FUTURES

    1,736.40
    +0.10 (+0.01%)
     
  • RUSSELL 2000

    2,247.72
    +18.79 (+0.84%)
     
  • 10-Yr Bond

    1.6380
    +0.0150 (+0.92%)
     
  • NASDAQ futures

    13,820.50
    +21.75 (+0.16%)
     
  • VOLATILITY

    16.99
    +0.34 (+2.04%)
     
  • FTSE

    6,939.58
    +49.09 (+0.71%)
     
  • NIKKEI 225

    29,620.99
    +82.29 (+0.28%)
     
  • CAD/EUR

    0.6666
    +0.0001 (+0.02%)
     

Pacira BioSciences to Present at the 2021 Barclays Global Healthcare Conference

  • Oops!
    Something went wrong.
    Please try again later.
Pacira Pharmaceuticals, Inc.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

PARSIPPANY, N.J., March 03, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 2021 Barclays Global Healthcare Conference at 10:55 AM ET on Tuesday, March 9, 2021. Live audio of the virtual event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event.

About Pacira

Pacira BioSciences, Inc. (Nasdaq: PCRX) is the industry leader in its commitment to non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. The company’s long-acting local analgesic, EXPAREL® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In April 2019, Pacira acquired the iovera°® system, a handheld cryoanalgesia device used to deliver precise, controlled doses of cold temperature only to targeted nerves. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.

CONTACT: Company Contact: Pacira BioSciences, Inc. Christian Pedetti (973) 254-4387 Christian.pedetti@pacira.com